| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/07/2006 | US6995006 Incubating a producer cell in a cell culture medium; wherein the producer cell is other than a KB cell, whereby greater than about 102 particles are produced from the producer cell |
| 02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
| 02/02/2006 | WO2006011669A1 Novel cinnamic acid related compounds |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | WO2006010422A1 Guanidine derivatives and therapeutic uses thereof |
| 02/02/2006 | WO2005097203A3 Serum protein conjugates of ion channel modulating compounds and uses thereof |
| 02/02/2006 | US20060025594 Small molecule entry inhibitors |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | US20060024523 Organic electroluminescence device |
| 02/02/2006 | CA2575359A1 Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 02/02/2006 | CA2574947A1 Guanidine derivatives and therapeutic uses thereof |
| 02/02/2006 | CA2574158A1 New benzoyl urea derivatives |
| 02/02/2006 | CA2571587A1 Quaternary salt ccr2 antagonists |
| 02/02/2006 | CA2570903A1 N-hydroxyamide derivatives and use thereof |
| 02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | CN1729180A Piperazinyl and diazapanyl benzamides and benzthioamides |
| 02/01/2006 | CN1729172A Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/01/2006 | CN1239487C Internediate for preparing quetiapin and preparation method of the intermediate |
| 02/01/2006 | CN1239467C Primary intermediates for oxidative coloration of hair |
| 01/31/2006 | US6992193 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 01/31/2006 | US6992190 Hydroxamic acid derivatives as antibacterials |
| 01/31/2006 | US6992095 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 01/31/2006 | US6992081 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/26/2006 | WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
| 01/26/2006 | WO2006009431A1 Process for the preparation of an (hetero)arylamine |
| 01/26/2006 | WO2006008753A1 Crystalline and amorphous form of ranolazine and the process for manufacturing them |
| 01/26/2006 | WO2005105766A3 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them |
| 01/26/2006 | US20060020147 Dispersing a quaternary alkyl ammonium salt to be purified into an acetone solvent to form a suspension of salt particles, quaternary alkyl ammonium salt being one of quaternary alkyl ammonium-tetrafluoroborate and quaternary alkyl ammonium-hexafluorophosphate;recovering, washing |
| 01/26/2006 | US20060020132 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence |
| 01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 01/26/2006 | US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections |
| 01/26/2006 | US20060020009 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 01/26/2006 | US20060018846 Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/26/2006 | US20060016023 Novel m-phenylenediamine derivatives as coupler components for the colouring of keratin fibres |
| 01/26/2006 | CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| 01/25/2006 | EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives |
| 01/25/2006 | EP1619188A1 Process for the preparation of monoaryl piperazines |
| 01/25/2006 | EP1619180A1 CaSR ANTAGONIST |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1617843A2 Colchicine derivatives |
| 01/25/2006 | EP1617841A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 01/25/2006 | EP1097158B1 Ligands for metals and metal-catalyzed processes |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1726200A Ionic liquids comprising [N(CF3)2] anions |
| 01/25/2006 | CN1726192A 3-amino-piperadine derivatives and methods of manufacture |
| 01/25/2006 | CN1726184A Animo substituted hydroxyphenyl benzophenone derivatives |
| 01/25/2006 | CN1724523A Long chain aromatic piperazine modified 2-(arylthio) benzylamin derivative and its preparation method and applicaltion |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/24/2006 | US6989264 Generating adenovirus-associated vector; obtain cells, transform with expression vector, propagate, recover transformed cells, propagate and recover vectors |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
| 01/19/2006 | CA2571572A1 Mitotic kinesin inhibitors |
| 01/18/2006 | EP1616867A1 Hydroxycarboxylic acid derivatives |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616859A1 Substituted cyclohexyl carboxylic acid compounds |
| 01/18/2006 | EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 01/18/2006 | EP1615866A1 Indene derivatives as pharmaceutical agents |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721415A Process for preparing N-acetyl morpholine |
| 01/18/2006 | CN1721407A New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/17/2006 | US6986833 For the preparation of dimethylpropylamine from dimethylamine and propionaldehyde in the presence of hydrogen |
| 01/17/2006 | US6986795 One cationic group Z, Z being chosen from quaternized aliphatic chains, aliphatic chains containing at least one quaternized saturated ring and aliphatic chains containing at least one quaternized unsaturated ring, their use as direct |
| 01/12/2006 | WO2006003329A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | WO2006003277A1 Aromatic biaryl products, compositions containing same and use as medicines |
| 01/12/2006 | WO2005108378A3 Use of (4-alkylpiperazinyl) (phenyl) methanones in the treatment of alzheimer’s disease |
| 01/12/2006 | US20060009651 Benzophenones as inhibitors of reverse transcriptase |
| 01/12/2006 | US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009449 Naphthaline derivatives as H3 inverse agonists |
| 01/12/2006 | US20060009448 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]thiomorpholin-3-one |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | DE102004030987A1 Ortho-substituierte (3-Hydroxyphenyl)-essigsäure-benzyliden-hydrazide Ortho-substituted (3-hydroxyphenyl) -acetic acid benzylidene-hydrazide |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2569545A1 Collection of traceable compounds and uses thereof |
| 01/12/2006 | CA2567020A1 Aromatic biaryl products, compositions containing same and use as medicines |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1613303A1 Substituted p-diaminobenzene derivatives |
| 01/11/2006 | EP1358169B1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | CN1235984C Fluorinated-photoinitiators in dual cure resins |
| 01/11/2006 | CN1235892C Gas-solid catalytic process for synthesizing piperazine from ethanediamine and ethandiol |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | US6984663 Cyclohexyl sulphones |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/05/2006 | WO2006000293A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 01/05/2006 | US20060004220 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents |